NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $171,000 | +3.0% | 10,036 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $166,000 | -28.4% | 10,036 | 0.0% | 0.01% | -35.7% |
Q2 2020 | $232,000 | +34.9% | 10,036 | +4.2% | 0.01% | +16.7% |
Q1 2020 | $172,000 | -17.3% | 9,633 | 0.0% | 0.01% | +9.1% |
Q4 2019 | $208,000 | -6.7% | 9,633 | -21.1% | 0.01% | -15.4% |
Q3 2019 | $223,000 | -24.4% | 12,216 | +47.3% | 0.01% | -27.8% |
Q2 2019 | $295,000 | +5.7% | 8,291 | 0.0% | 0.02% | +5.9% |
Q1 2019 | $279,000 | +5.3% | 8,291 | +2.8% | 0.02% | -5.6% |
Q4 2018 | $265,000 | -44.8% | 8,065 | +2.5% | 0.02% | -35.7% |
Q3 2018 | $480,000 | +21.8% | 7,868 | -2.6% | 0.03% | +16.7% |
Q2 2018 | $394,000 | -31.8% | 8,077 | +48.5% | 0.02% | -29.4% |
Q1 2018 | $578,000 | +57.5% | 5,438 | -11.5% | 0.03% | +61.9% |
Q4 2017 | $367,000 | +167.9% | 6,148 | +7.5% | 0.02% | +162.5% |
Q3 2017 | $137,000 | +6.2% | 5,721 | -13.2% | 0.01% | 0.0% |
Q2 2017 | $129,000 | -9.2% | 6,594 | +8.8% | 0.01% | -11.1% |
Q1 2017 | $142,000 | +82.1% | 6,059 | -5.0% | 0.01% | +80.0% |
Q4 2016 | $78,000 | -21.2% | 6,377 | +10.6% | 0.01% | -28.6% |
Q3 2016 | $99,000 | +22.2% | 5,767 | +1.9% | 0.01% | +16.7% |
Q2 2016 | $81,000 | +9.5% | 5,662 | +4.7% | 0.01% | 0.0% |
Q1 2016 | $74,000 | -10.8% | 5,408 | +9.9% | 0.01% | 0.0% |
Q4 2015 | $83,000 | +50.9% | 4,919 | -2.4% | 0.01% | +50.0% |
Q3 2015 | $55,000 | -12.7% | 5,038 | 0.0% | 0.00% | -20.0% |
Q2 2015 | $63,000 | – | 5,038 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |